Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The Medical Team will help you select a schedule that matches that
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
Spacing protein evenly across meals (every 34 hours)
This is the same additional pathway that tirzepatide uses beyond semaglutide
US$ 23.32
US$ 25.26
US$ 26.24
